Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 14234

Boise, ID 83704


Study Summary:

A multicenter, randomized, double blind, placebo controlled, 8-week study to evaluate the safety and efficacy of nebivolol and valsartan given as a fixed-dose combination in patients with stage 1 or 2 essential hypertension.


Qualified Participants Must:

• Patients diagnosed with stage 1 or stage 2 essential hypertension
• Be currently being treated for hypertension with at least 1 documented DBP value ≥ 90 and < 110 mm Hg in their medical history or at a recent time during prescreening
• Be newly diagnosed with essential hypertension who have never received treatment
• Have a mean sitting DBP > 95 and < 110 mm Hg at Screening (Visit 1)
• Been previously diagnosed and who have not received antihypertensive medications for at least 4 weeks prior to Screening (Visit 1) must have a mean sitting DBP > 95 and < 110 mm Hg at screening (Visit 1)
• Have a sitting pulse rate of at least 55 bpm at Screening


Qualified Participants May Receive:

Compensation for time and travel


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.